Medicine Image
Medicine Name:
ZALTRAP
Generic Name:
ziv - aflibercept
Company Name:
Sanofi-Aventis
Packing:
100 mg per 4 ml (25 mg/ml) , 200 mg per 8 ml (25 mg/ml)
Enquiry:
Fill Form For Medicine Enquiry   

ZALTRAP Injection for intravenous use (ziv – aflibercept)

Description of Zaltrap (Ziv-aflibercept)
Zaltrap is an anti-neoplastic agent, that is a Tyrosine Kinase inhibitor

Indications
Zaltrap is indicated in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) for metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin regimen.

Treatment
For treatment related information, please consult your treating Physician.

How supplied
Zaltrap is supplied in a carton containing (1) single use vial of 100 mg per 4 ml (25 mg/ml)
Zaltrap is supplied in a carton containing (1) single use vial of 200 mg per 8 ml (25 mg/ml)

Storage and handling
Store Zaltrap vials in a refrigerator at 2°- 8° C. Keep the vials in the original outer carton to protect from light.

How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s Sanofi

Contact Details:
Mob No: +91 7738100125, +91 7738151650
E Mail: imports@specialitiespharma.com